320 results on '"Yorioka N"'
Search Results
2. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life
3. Osteoprotegerin and bone mineral density in hemodialysis patients
4. Ultrastructural localization of vascular cell adhesion molecule-1 in proliferative and crescentic glomerulonephritis
5. PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation
6. HMG-CoA reductase inhibitors prevent bone loss in patients with Type 2 diabetes mellitus
7. Apolipoprotein E Phenotype and Renal Disease
8. Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
9. Primary and secondary glomerulonephritis II
10. Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: A mechanism for activation of latent TGF-beta 1.
11. Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients
12. Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life
13. Renal histology before and after effective enzyme replacement therapy in a patient with classical Fabry’s disease
14. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis
15. Oral mizoribine pulse therapy for steroid-dependent focal segmental glomerulosclerosis
16. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerois (FGS)
17. Radial Bone Mineral Density in Hemodialysis Patients with Adynamic Bone Disease
18. Reiter's Syndrome Associated with HLA-B51: A Case Report
19. Dose-Dependent Effect of an Oral Adsorbent, AST-120, in Patients with Early Chronic Renal Failure
20. Direct Infusion of Ascites into the Blood Circuit during Hemodiafiltration in Uremic Patients with Cirrhosis
21. Lipid-Lowering Therapy and Coagulation/Fibrinolysis Parameters in Patients on Peritoneal Dialysis
22. Evaluation of the PD Adequest Program in Japanese Patients on Peritoneal Dialysis
23. A Case of Antiphospholipid Antibody Syndrome Diagnosed after Thrombosis of an Arteriovenous Shunt
24. Dextran Sulfate-Cellulose Adsorption in the Management of a Myeloma Patient with Renal Amyloidosis
25. Correction of CAPD Catheter Displacement Using Gastric Biopsy Forceps: The Push-Pull Method
26. Factors Influencing Arteriovenous Fistula Dysfunction in Japanese Patients on Chronic Hemodialysis
27. Tissue Factor and Tissue Factor Pathway Inhibitor in Hemodialysis Patients
28. Effects of Dialysis Membranes on the Kinetics of Tumor Necrosis Factor-α Production by Peripheral Mononuclear Cells in Chronic Hemodialysis Patients
29. Dose Escalation Induces Tolerance to Side-Effects of Erythropoietin in a Patient with Dialysis Anaemia: Case Report
30. CAPD catheter rupture without deterioration
31. Low-Density Lipoprotein Apheresis for Focal Glomerular Sclerosis
32. Role of Tenascin in Human Immunoglobulin a Nephropathy
33. Role of Transforming Growth Factor-β and -β in ddY Mous Nephropathy
34. Investigation of the Influenza-Like Symptoms Associated with Recombinant Human Erythropoietin Therapy
35. Case Report of a Patient with Bilateral Renal Cell Carcinoma Successfully Maintained on Continuous Ambulatory Peritoneal Dialysis after Bilateral Nephrectomy
36. Role of Transforming Growth Factor-β1 in Glomerulonephritis
37. Stimulation of Interleukin-1 ß Production may be Involved in Unresponsiveness to Erythropoietin Therapy
38. Usefulness of Immunoadsorption Therapy for Systemic Lupus Erythematosus Associated with Transverse Myelitis. A Case Report
39. Dose conversion ratio one year after switching from epoetin alpha to darbepoetin alpha in Japanese hemodialysis patients.
40. Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.
41. Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy.
42. Screening for gastroenterological malignancies in new and maintenance dialysis patients.
43. Localization of hepatocyte growth factor and tubulointerstitial lesions in IgA nephropathy.
44. Serum soluble interleukin-2 receptor in patients with glomerulonephritis.
45. Effects of dialysis membranes on the kinetics of tumor necrosis factor-alpha production by peripheral mononuclear cells in chronic hemodialysis patients.
46. Serum Cross-Linked N-Terminal Telopeptide of Type I Collagen for Evaluation of Renal Osteodystrophy in Hemodialysis Patients
47. Effect of Glucose Polymer on the Intercellular Junctions of Cultured Human Peritoneal Mesothelial Cells
48. Role of Transforming Growth Factor-β1in Glomerulonephritis
49. Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophil cytoplasmic antibody-associated nephritis.
50. Fatal hepatic failure caused by miliary tuberculosis in a hemodialysis patient: Case report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.